Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang, CH Lee… - Nuclear medicine …, 2004 - journals.lww.com
Background In the management of patients with differentiated thyroid carcinoma, direct
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131 I with …
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131 I with …
Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang, CH Lee… - Nuclear medicine …, 2004 - pubmed.ncbi.nlm.nih.gov
Background In the management of patients with differentiated thyroid carcinoma, direct
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131I with …
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131I with …
Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang, CH Lee… - Nuclear Medicine …, 2004 - pure.lib.cgu.edu.tw
Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid
carcinoma: discrepancy between the presence of visually apparent stunning and the …
carcinoma: discrepancy between the presence of visually apparent stunning and the …
Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang… - Nuclear Medicine …, 2004 - researchoutput.ncku.edu.tw
Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid
carcinoma: discrepancy between the presence of visually apparent stunning and the …
carcinoma: discrepancy between the presence of visually apparent stunning and the …
Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang, CH Lee… - Nuclear Medicine …, 2004 - europepmc.org
Background In the management of patients with differentiated thyroid carcinoma, direct
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131I with …
comparison of the presence of scintigraphic stunning after a diagnostic dose of 131I with …
Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent …
YH Hu, PW Wang, ST Wang, CH Lee… - Nuclear Medicine …, 2004 - pure.lib.cgu.edu.tw
Influence of i diagnostic dose on subsequent ablation in patients with differentiated thyroid
carcinoma: discrepancy between the presence of visually apparent stunning and the …
carcinoma: discrepancy between the presence of visually apparent stunning and the …